BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 29960865)

  • 1. The role of kidney in the inter-organ coordination of endogenous glucose production during fasting.
    Kaneko K; Soty M; Zitoun C; Duchampt A; Silva M; Philippe E; Gautier-Stein A; Rajas F; Mithieux G
    Mol Metab; 2018 Oct; 16():203-212. PubMed ID: 29960865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal gluconeogenesis is crucial to maintain a physiological fasting glycemia in the absence of hepatic glucose production in mice.
    Penhoat A; Fayard L; Stefanutti A; Mithieux G; Rajas F
    Metabolism; 2014 Jan; 63(1):104-11. PubMed ID: 24135501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of blood glucose in the absence of hepatic glucose production during prolonged fasting in mice: induction of renal and intestinal gluconeogenesis by glucagon.
    Mutel E; Gautier-Stein A; Abdul-Wahed A; Amigó-Correig M; Zitoun C; Stefanutti A; Houberdon I; Tourette JA; Mithieux G; Rajas F
    Diabetes; 2011 Dec; 60(12):3121-31. PubMed ID: 22013018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context.
    Monteillet L; Gjorgjieva M; Silva M; Verzieux V; Imikirene L; Duchampt A; Guillou H; Mithieux G; Rajas F
    Mol Metab; 2018 Oct; 16():100-115. PubMed ID: 30100243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Mediator complex kinase module is necessary for fructose regulation of liver glycogen levels through induction of glucose-6-phosphatase catalytic subunit (G6pc).
    Youn DY; Xiaoli AM; Zong H; Okada J; Liu L; Pessin J; Pessin JE; Yang F
    Mol Metab; 2021 Jun; 48():101227. PubMed ID: 33812059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased fasting blood glucose is associated with impaired hepatic glucose production in thyroid-stimulating hormone receptor knockout mice.
    Wang T; Xu J; Bo T; Zhou X; Jiang X; Gao L; Zhao J
    Endocr J; 2013; 60(8):941-50. PubMed ID: 23665701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose toxicity is responsible for the development of impaired regulation of endogenous glucose production and hepatic glucokinase in Zucker diabetic fatty rats.
    Fujimoto Y; Torres TP; Donahue EP; Shiota M
    Diabetes; 2006 Sep; 55(9):2479-90. PubMed ID: 16936196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
    Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
    J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic lentiviral gene transfer prevents the long-term onset of hepatic tumours of glycogen storage disease type 1a in mice.
    Clar J; Mutel E; Gri B; Creneguy A; Stefanutti A; Gaillard S; Ferry N; Beuf O; Mithieux G; Nguyen TH; Rajas F
    Hum Mol Genet; 2015 Apr; 24(8):2287-96. PubMed ID: 25561689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic protein phosphatase 1 regulatory subunit 3B (Ppp1r3b) promotes hepatic glycogen synthesis and thereby regulates fasting energy homeostasis.
    Mehta MB; Shewale SV; Sequeira RN; Millar JS; Hand NJ; Rader DJ
    J Biol Chem; 2017 Jun; 292(25):10444-10454. PubMed ID: 28473467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocytes contribute to residual glucose production in a mouse model for glycogen storage disease type Ia.
    Hijmans BS; Boss A; van Dijk TH; Soty M; Wolters H; Mutel E; Groen AK; Derks TGJ; Mithieux G; Heerschap A; Reijngoud DJ; Rajas F; Oosterveer MH
    Hepatology; 2017 Dec; 66(6):2042-2054. PubMed ID: 28727166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels.
    Saeed A; Hoogerland JA; Wessel H; Heegsma J; Derks TGJ; van der Veer E; Mithieux G; Rajas F; Oosterveer MH; Faber KN
    Hum Mol Genet; 2020 Jan; 29(2):264-273. PubMed ID: 31813960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent hypoglycemia increases hepatic gluconeogenesis without affecting glycogen metabolism or systemic lipolysis in rat.
    Liu Z; Zhang L; Qian C; Zhou Y; Yu Q; Yuan J; Lv Y; Zhang L; Chang X; Li Y; Liu Y
    Metabolism; 2022 Nov; 136():155310. PubMed ID: 36063868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy.
    Lee YM; Jun HS; Pan CJ; Lin SR; Wilson LH; Mansfield BC; Chou JY
    Hepatology; 2012 Nov; 56(5):1719-29. PubMed ID: 22422504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of hepatic glycogen breakdown in defective counterregulation of hypoglycemia in intensively treated type 1 diabetes.
    Kishore P; Gabriely I; Cui MH; Di Vito J; Gajavelli S; Hwang JH; Shamoon H
    Diabetes; 2006 Mar; 55(3):659-66. PubMed ID: 16505228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The absence of hepatic glucose-6 phosphatase/ChREBP couple is incompatible with survival in mice.
    Rajas F; Dentin R; Cannella Miliano A; Silva M; Raffin M; Levavasseur F; Gautier-Stein A; Postic C; Mithieux G
    Mol Metab; 2021 Jan; 43():101108. PubMed ID: 33137488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zbtb7c is a critical gluconeogenic transcription factor that induces glucose-6-phosphatase and phosphoenylpyruvate carboxykinase 1 genes expression during mice fasting.
    Choi WI; Yoon JH; Song JY; Jeon BN; Park JM; Koh DI; Ahn YH; Kim KS; Lee IK; Hur MW
    Biochim Biophys Acta Gene Regul Mech; 2019 Jun; 1862(6):643-656. PubMed ID: 30959128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-α activity restored are at risk of developing hepatic tumors.
    Kim GY; Lee YM; Kwon JH; Cho JH; Pan CJ; Starost MF; Mansfield BC; Chou JY
    Mol Genet Metab; 2017 Mar; 120(3):229-234. PubMed ID: 28096054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons from new mouse models of glycogen storage disease type 1a in relation to the time course and organ specificity of the disease.
    Rajas F; Clar J; Gautier-Stein A; Mithieux G
    J Inherit Metab Dis; 2015 May; 38(3):521-7. PubMed ID: 25164786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.